Dr. Lily Chan leads NUS Enterprise at the National University of Singapore (NUS), with the vision to inject an enterprise dimension into NUS teaching and research involving the University’s students, staff and alumni. The Enterprise Cluster comprises several divisions for entrepreneurship support, experiential education and technology innovation and commercialisation.As the CEO, Dr. Chan spearheads strategies and initiatives to promote industry collaboration and business ventures for the University. In addition, she oversees the functions of the Enterprise Cluster, which complements the academic cluster of the University by nurturing talents with an entrepreneurial and global mindset.
Prior to joining NUS in 2006, Dr. Chan held the position of Managing Director, Investments, of Bio*One Capital Pte Ltd, an investment arm of the Singapore Economic Development Board, with the focus of expanding the growth of the biomedical science industry in Singapore. Dr Chan brings with her more than 20 years of industry experience, from initiating start-ups and venture investments, to active Board involvement in many startup companies. She has also served on several national-level committees on enterprise and innovation.
Dr. Chan started her career as a research scientist with the NUS Department of Medicine. One of the first research scientists to be hired by the Department, her research focused on hepatitis and liver cancer, epidemiology, tumour markers and diabetes. She later joined the industry, becoming the QC/Technical Manager for Singapore Biotech Pte Ltd. She went on to assume positions of increasing responsibility, from Manager in product development to subsequently becoming the General Manager (Singapore), and Director of Product Development (USA) for Genelabs Diagnostics Pte Ltd Singapore.
Dr Chan holds three issued US patents in the field of infectious diseases. These are now utilized as commercial products in the diagnostic arena.
Dr Chan obtained her honours degree B.A (Biology) at Agnes Scott College, Decatur, Georgia, USA. She completed her PhD (Microbiology and Immunology) at the University of Illinois at the Medical Center, Chicago, Illinois, USA.